SWKH News and Press, SWK Holdings Corporation From 10/26/21

Enteris BioPharma to Participate in the Partnership Opportunities in Drug Delivery (PODD) 2021 Conference PR Newswire BOONTON, N.J. , Oct. 26, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on...

Enteris BioPharma to Participate in the American Association of Pharmaceutical Scientists (AAPS) 2021 PHARMSCI 360 Conference PR Newswire BOONTON, N.J. , Oct. 13, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative dr...

Enteris BioPharma Announces Successful Completion of Phase 1 Clinical Trial of Optimized Peptelligence® Oral Leuprolide Data indicates optimized Peptelligence oral leuprolide formulation delivers comparable or greater drug levels than subcutaneous or depot injection PR ...

Enteris BioPharma Receives 2021 Best of Boonton Award Enteris recognized for the third consecutive year in Pharmaceutical Company category PR Newswire BOONTON, N.J. , Aug. 23, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developi...

SWK Holdings Corporation (SWKH) Q2 2021 Earnings Conference Call August 17, 2021, 10:00 AM ET Company Participants Maureen McEnroe - EVP, Tiberend Strategic Advisors, IR Winston Black - Chairman and CEO Conference Call Participants Kyle Bauser - Colliers Securities Michael Diana - Maxim Group...

SWK Holdings Corporation Announces Financial Results for Second Quarter 2021 Conference Call and Live Audio Webcast Scheduled for Tuesday, August 17, 2021 at 10:00 a.m. ET PR Newswire DALLAS , Aug. 16, 2021 /PRNewswire/ -- Corporate Updates The ...

Silicon Labs Completes Divestiture of Infrastructure & Automotive Business Silicon Labs Completes Divestiture of Infrastructure & Automotive Business Transformation to Pure-Play Leader of Secure, Intelligent Wireless Connectivity for the IoT Now Complete PR Newsw...

Enteris BioPharma to Host Webinar on High Potency Active Pharmaceutical Ingredients in Oral Drug Development PR Newswire BOONTON, N.J. , June 15, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based ...

SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics Third milestone payment related to the development of Oral KORSUVA™ PR Newswire DALLAS , June 11, 2021 /PRNewswire/ -- SWK Holdings Corporation (...

Enteris BioPharma to Participate in BIO Digital 2021 PR Newswire BOONTON, N.J. , June 7, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-ow...